Skip to content
Search

Latest Stories

Double vaccinated NHS and social care staff allowed to attend work in exceptional circumstances

The government has allowed double vaccinated frontline NHS and social care staff in England who have been asked to self-isolate to attend work in exceptional circumstances and replaced by testing mitigations from Monday (July 19).

This measure is being introduced to alleviate pressure on NHS and social care services and will be contingent on staff members only working after having a negative PCR test and also taking daily negative lateral flow tests for a minimum of seven days, and up to 10 days or completion of the identified self-isolation period.


The government is clear the change applies only to frontline NHS and social care staff where their absence may lead to a significant risk of harm.

The decision to allow NHS and social care staff to attend work will be taken only after a risk assessment by the organisation’s management.

This must be authorised by the organisation’s local Director of Infection Prevention and Control, the lead professional for health protection, or the Director of Public Health relevant to the organisation.

Health Secretary Sajid Javid said, "As we learn to live with this virus, it’s important that we ensure frontline staff can keep providing the best possible care and support to people up and down the country.

"Staff who are permitted to attend work will remain under a legal duty to self-isolate as a close contact when not at work, but will be considered to have a ‘reasonable excuse’ under the Self-Isolation regulations to leave self-isolation to attend work where their absence could result in harm. They will continue to receive self-isolation reminders."

UK Health Security Agency chief executive, Jenny Harries, said, "With the number of cases continuing to rise, it is imperative that we do everything we can to manage this virus and support our NHS and social care services under the strain of increased demand and sustained pressure."

We have provided specific guidance to NHS and social care settings for circumstances where there is a significant risk to health or safety resulting from staff absence or a critical service cannot run.

This measure only applies to double vaccinated staff, who will only be able to attend work after testing negative on PCR and daily lateral flow tests, and following a risk assessment and the supervision of the health service.

In order to mitigate the increased risk associated with attending work, the following mitigations must be implemented:

The staff member should be fully vaccinated, defined as having received both doses of an MHRA approved vaccination, with 14 days having elapsed since the final dose.

The staff member should undertake a PCR test and should self-isolate until they receive the result. They should only attend work if this result is negative.

They should undertake daily LFD tests prior to starting work each day. Test results should be reported to NHS Test and Trace via the web portal and to their duty manager. Any staff member who has a positive LFD test during this period should not attend work and should arrange a PCR test as soon as possible.

If the staff member develops any COVID symptoms, they should stay at home and immediately arrange a PCR test.

Staff working during this 10-day period should comply with all relevant infection control precautions and PPE should be properly worn throughout the day. Any breaches should be reported immediately to their line manager.

The staff member should not work with clinically extremely vulnerable patients or residents, as determined by the organisation.

More For You

RPS backs Pharmacist Support "Gift in Wills" initiative

The ‘Gift in Wills’ initiative is delivered in partnership with Bequeathed.

Photo credit: gettyimages

Leave a legacy: RPS partners with Pharmacist Support to promote ‘Gift in Wills’

The Royal Pharmaceutical Society (RPS) has announced its support for the ‘Gift in Wills’ initiative run by Pharmacist Support, coinciding with the charity’s birthday celebrations today (Tuesday 15 April).

This collaboration allows RPS members to create a free will while also helping to safeguard the future of vital support services for the pharmacy profession.

Keep ReadingShow less
Pharmacist Support calls for birthday donations to meet rising demand for mental health services

More and more pharmacy professionals are reaching out for help, said Danielle Hunt.

Pharmacist Support's birthday appeal: Donate to address growing mental health demand

Pharmacist Support – the independent charity dedicated to the pharmacy profession – is celebrating 184 years of service with the launch of a special birthday donations appeal.

On 15 April, the charity is urging individuals and organisations across the sector to support its campaign to raise vital funds to meet the increasing demand for its mental health and wellbeing services.

Keep ReadingShow less
Prostate cancer: At-home saliva test could save NHS £500 million annually

PRS saliva test can identify prostate cancer that was missed by an MRI scan

Photo credit: gettyimages

Prostate cancer: Spit test better than blood test in spotting men at highest risk

A simple at-home spit test could help detect prostate cancer earlier, saving the NHS around £500 million a year, according to new research published in the New England Journal of Medicine.

Funded by the National Institute for Health and Care Research (NIHR), the study found that the DNA-based saliva test was more accurate than the current prostate-specific antigen (PSA) blood test in identifying men at risk of developing prostate cancer.

Keep ReadingShow less
RPS launches innovative new learning resources for members

With RPS Learn, pharmacists can develop a new skill or improve their understanding of practice or a clinical topic.

Gettyimages

RPS launches new learning resources to boost career development for members

The Royal Pharmaceutical Society (RPS) has launched a new online learning platform designed to support the practice, development and career advancement of its members.

The new platform, called RPS Learn, offers a diverse range of bite-size learning content, available on-demand, catering to all levels — from introductory to advanced and specialist —combining new content with RPS's renowned expertise in education and training to achieve excellence for learners.

Keep ReadingShow less
NICE approves AstraZeneca’s twice-a-day tablet ‘capivasertib’ for advanced breast cancer

HR-positive, HER2-negative advanced breast cancer is currently incurable, and treatment aims to slow progression and prolong life

Gettyimages

NICE approves twice-a-day tablet for advanced breast cancer

Every year, thousands of people with hormone receptor (HR)-positive HER2-negative breast cancer could benefit from a new twice-a-day tablet, now set to be funded immediately through the Cancer Drugs Fund.

The National Institute for Health and Care Excellence (NICE) has approved the use of capivasertib (also known as Truqap), in combination with fulvestrant, as an option for around 1,100 adults with HR-positive HER2-negative breast cancer that has certain genetic mutations and has spread.

Keep ReadingShow less